Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Its only approved for people living with type 2 diabetes
The physical benefits of exercise remain a critical complement to pharmacological treatment, and physicians who can counsel patients on integrating movement with GLP-1 therapy will deliver more comprehensive metabolic care
Retatrutide Phase 3 TRIUMPH-4 data (December 2025): 28.7% mean weight loss at 68 weeks with 12 mg
Effectiveness for Weight Loss: Clinical studies show that tirzepatide has a slight edge over semaglutide in terms of weight loss results
US$ 22.67
US$ 20.30
US$ 28.87
US$ 26.64
US$ 21.91
US$ 29.94
US$ 29.72
US$ 23.87
